Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferences.
暂无分享,去创建一个
F. Guillemin | A. Saraux | J. Berthelot | B. Combe | O. Meyer | B. Fautrel | D. Wendling | R. Flipo | X. le Loët | J. Maillefert | F. Lioté | M. de Bandt